Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial

Eric Lawitz, Fred Poordad, Phillip S. Pang, Robert H. Hyland, Xiao Ding, Hongmei Mo, William T. Symonds, John G. McHutchison, Fernando E. Membreno

The Lancet · 2013 · 549 citations · 22 references

Concepts

References

22